The consequences of refractory epilepsy and its treatment

Epilepsy and Behavior

Volumn 37, Issue , 2014, Pages 59-70

  Laxer, Kenneth D ^a   Trinka, Eugen ^b,c   Hirsch, Lawrence J ^d   Cendes, Fernando ^e   Langfitt, John ^f,g   Delanty, Norman ^h   Resnick, Trevor ⁱ   Benbadis, Selim R ^j  

^a CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

^b PARACELSUS MEDICAL UNIVERSITY   (Austria)

^c UNIVERSITY OF SALZBURG   (Austria)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF CAMPINAS   (Brazil)

^f UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^g STRONG MEMORIAL HOSPITAL   (United States)

^h BEAUMONT HOSPITAL   (Ireland)

ⁱ MIAMI CHILDREN'S HOSPITAL   (United States)

^j UNIVERSITY OF SOUTH FLORIDA   (United States)

more..

Author keywords

Antiepileptic treatment; Comorbidities; Epilepsy; Mortality; Safety; Sudden unexpected death in epilepsy

Indexed keywords

ADENOSINE; ALCOHOL; ANTICONVULSIVE AGENT; CARBAMAZEPINE; CARBON DIOXIDE; ETIRACETAM; LAMOTRIGINE; OPIATE; OXYGEN; SEROTONIN; TOPIRAMATE; VALPROIC ACID; VIGABATRIN;

ACCIDENT; ACIDOSIS; ALCOHOL CONSUMPTION; ANTICONVULSANT THERAPY; ANXIETY; APLASTIC ANEMIA; APNEA; ASSAULT; ATTENTION DEFICIT DISORDER; BLEEDING; BODY POSTURE; BRAIN DAMAGE; BRAIN DEPTH STIMULATION; BRAIN SURGERY; CAUSE OF DEATH; CEREBELLUM ATROPHY; COMORBIDITY; CONSTIPATION; CORPUS CALLOSOTOMY; DEHYDRATION; DEPRESSION; DIET THERAPY; DISEASE COURSE; DISEASE DURATION; DRIVE; DROWNING; DRUG INTOXICATION; DRUG RESISTANCE; DRUG SAFETY; EDUCATION; EPILEPSY; EPILEPTOGENESIS; FALLING; FRACTURE; GASTROINTESTINAL SYMPTOM; HEART ARREST; HEART ARRHYTHMIA; HEMIPLEGIA; HEMISPHERECTOMY; HORMONE DEFICIENCY; HUMAN; HYDROCEPHALUS; HYPOGLYCEMIA; HYPOXEMIA; KETOGENIC DIET; LARYNX SPASM; LONG TERM CARE; LYMPHOMA; MEMORY DISORDER; MENTAL DISEASE; META ANALYSIS (TOPIC); METABOLIC DISORDER; MORTALITY; NAUSEA; NERVE STIMULATION; NEUROIMAGING; NEUROLOGIC DISEASE; NONHUMAN; NUTRITIONAL DEFICIENCY; OSTEOPOROSIS; OXYGEN SATURATION; PNEUMONIA; POSTOPERATIVE COMPLICATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); REBREATHING; RESPONSIVE NEUROSTIMULATION; RETINA DISEASE; RETINOPATHY; REVIEW; RISK FACTOR; SLEEP DEPRIVATION; SOCIAL STIGMA; SPREADING CORTICAL DEPRESSION; SUDDEN DEATH; SUICIDE; TEMPORAL LOBECTOMY; TRAFFIC ACCIDENT; TREATMENT OUTCOME; TREATMENT RESPONSE; VAGUS NERVE STIMULATION; VASCULAR DISEASE; VISUAL IMPAIRMENT; VOCATION; WOUND INFECTION; ECONOMIC ASPECT; SOCIAL PSYCHOLOGY; COMPLICATION;

ANTICONVULSANTS; DRUG RESISTANCE; EPILEPSY; HUMANS;

EID: 84903470405     PISSN: 15255050     EISSN: 15255069     Source Type: Journal    
DOI: 10.1016/j.yebeh.2014.05.031     Document Type: Review

References (228)

1. World Health Organization (WHO) "Epilepsy". WHO Factsheet, October 2012: number 999 2014, Available at: www.who.int/mediacentre/factsheets/fs999/en/index.htmlAccessed Jan. 7, 2014.
2. Banerjee P.N., Filippi D., Allen Hauser W. The descriptive epidemiology of epilepsy - a review. Epilepsy Res 2009, 85:31-45.
3. Prischich F., De Rinaldis M., Bruno F., Egeo G., Santori C., Zappaterreno A., et al. High prevalence of epilepsy in a village in the Littoral Province of Cameroon. Epilepsy Res 2008, 82:200-210.
4. Picot M.C., Baldy-Moulinier M., Daurès J.P., Dujols P., Crespel A. The prevalence of epilepsy and pharmacoresistant epilepsy in adults: a population-based study in a Western European country. Epilepsia 2008, 49:1230-1238.
5. World Health Organization (WHO). The Global Burden of Disease: 2004 Update 2014, Available at: www.who.int/healthinfo/global_burden_disease/GBD_report_2004update_full.pdfAccessed Jan. 7, 2014.
6. Gaitatzis A., Johnson A.L., Chadwick D.W., Shorvon S.D., Sander J.W. Life expectancy in people with newly diagnosed epilepsy. Brain 2004, 127:2427-2432.
7. Trinka E. Epilepsy: comorbidity in the elderly. Acta Neurol Scand 2003, 108(Suppl. 180):33-36.
8. McCagh J., Fisk J.E., Baker G.A. Epilepsy, psychosocial and cognitive functioning. Epilepsy Res 2009, 86:1-14.
9. Spatt J., Bauer G., Baumgartner C., Feucht M., Graf M., Mamoli B., et al. Austrian Section of the International League Against Epilepsy Predictors for negative attitudes toward subjects with epilepsy: a representative survey in the general public in Austria. Epilepsia 2005, 46:736-742.
10. Lhatoo S.D., Johnson A.L., Goodridge D.M., MacDonald B.K., Sander J.W., Shorvon S.D. Mortality in epilepsy in the first 11 to 14 years after diagnosis: multivariate analysis of a long-term, prospective, population-based cohort. Ann Neurol 2001, 49:336-344.
11. Mohanraj R., Norrie J., Stephen L.J., Kelly K., Hitiris N., Brodie M.J. Mortality in adults with newly diagnosed and chronic epilepsy: a retrospective comparative study. Lancet Neurol 2006, 5:481-487.
12. Trinka E., Bauer G., Oberaigner W., Ndayisaba J.P., Seppi K., Granbichler C.A. Cause-specific mortality among patients with epilepsy: results from a 30-year cohort study. Epilepsia 2013, 54:495-501.
13. Gaitatzis A., Sisodiya S.M., Sander J.W. The somatic comorbidity of epilepsy: a weighty but often unrecognized burden. Epilepsia 2012, 53:1282-1293.
14. Dobesberger J., Walser G., Unterberger I., Seppi K., Kuchukhidze G., Larch J., et al. Video-EEG monitoring: safety and adverse events in 507 consecutive patients. Epilepsia 2011, 52:443-452.
15. Hedegärd E., Bjellvi J., Edelvik A., Rydenhag B., Flink R., Malmgren K. Complications to invasive epilepsy surgery workup with subdural and depth electrodes: a prospective population-based observational study. J Neurol Neurosurg Psychiatry 2014, 85:716-720.
16. Ehling R., Dobesberger J., Unterberger I., Benke T., Gotwald T., Ortler M., et al. Selective amygdalo-hippocampectomy as a potential trigger for disease progression in multiple sclerosis. Clin Neurol Neurosurg 2011, 113:136-138.
17. Endo Y., Saito Y., Otsuki T., Takahashi A., Nakata Y., Okada K., et al. Persistent verbal and behavioral deficits after resection of the left supplementary motor area in epilepsy surgery. Brain Dev 2014, 36:74-79.
18. Georgiadis I., Kapsalaki E.Z., Fountas K.N. Temporal lobe resective surgery for medically intractable epilepsy: a review of complications and side effects. Epilepsy Res Treat 2013, 752195. [E-pub ahead of print 2013 Oct 31]. 10.1155/2013/752195.
19. Roth J., Carlson C., Devinsky O., Harter D.H., Macallister W.S., Weiner H.L. Safety of Staged Epilepsy Surgery in Children. Neurosurgery 2014, 74:154-162.
20. Forsgren L., Beghi E., Oun A., Sillanpää M. The epidemiology of epilepsy in Europe - a systematic review. Eur J Neurol 2005, 12:245-253.
21. Sander J.W. The epidemiology of epilepsy revisited. Curr Opin Neurol 2003, 16:165-170.
22. Everitt A.D., Sander J.W. Incidence of epilepsy is now higher in elderly people than children. Br Med J 1998, 316:780.
23. Brodie M.J., Kwan P. Epilepsy in elderly people. Br Med J 2005, 331:1317-1322.
24. Winkler A.S., Kerschbaumsteiner K., Stelzhammer B., Meindl M., Kaaya J., Schmutzhard E. Prevalence, incidence, and clinical characteristics of epilepsy - a community-based door-to-door study in northern Tanzania. Epilepsia 2009, 50:2310-2313.
25. Kwan P., Sander J.W. The natural history of epilepsy: an epidemiological view. J Neurol Neurosurg Psychiatry 2004, 75:1376-1381.
26. Shorvon S.D. The temporal aspects of prognosis in epilepsy. J Neurol Neurosurg Psychiatry 1984, 47:1157-1165.
27. Shorvon S., Luciano A.L. Prognosis of chronic and newly diagnosed epilepsy: revisiting temporal aspects. Curr Opin Neurol 2007, 20:208-212.
28. Berg A.T., Langfitt J., Shinnar S., Vickrey B.G., Sperling M.R., Walczak T., et al. How long does it take for partial epilepsy to become intractable?. Neurology 2003, 60:186-190.
29. Berg A.T. Understanding the delay before epilepsy surgery: who develops intractable focal epilepsy and when?. CNS Spectr 2004, 9:136-144.
30. Luciano A.L., Shorvon S.D. Results of treatment changes in patients with apparently drug-resistant chronic epilepsy. Ann Neurol 2007, 62:375-381.
31. Callaghan B.C., Anand K., Hesdorffer D., Hauser W.A., French J.A. Likelihood of seizure remission in an adult population with refractory epilepsy. Ann Neurol 2007, 62:382-389.
32. Neligan A., Bell G.S., Elsayed M., Sander J.W., Shorvon S.D. Treatment changes in a cohort of people with apparently drug-resistant epilepsy: an extended follow-up. J Neurol Neurosurg Psychiatry 2012, 83:810-813.
33. Callaghan B., Schlesinger M., Rodemer W., Pollard J., Hesdorffer D., Allen Hauser W., et al. Remission and relapse in a drug-resistant epilepsy population followed prospectively. Epilepsia 2011, 52:619-626.
34. Wiebe S., Blume W.T., Girvin J.P., Eliasziw M. Effectiveness and Efficiency of Surgery for Temporal Lobe Epilepsy Study Group. A randomized, controlled trial of surgery for temporal-lobe epilepsy. N Engl J Med 2001, 345:311-318.
35. Engel J., McDermott M.P., Wiebe S., Langfitt J.T., Stern J.M., Dewar S., et al. Early Randomized Surgical Epilepsy Trial (ERSET) Study Group. Early surgical therapy for drug-resistant temporal lobe epilepsy: a randomized trial. JAMA 2012, 307:922-930.
36. Kwan P., Arzimanoglou A., Berg A.T., Brodie M.J., Allen Hauser W., Mathern G., et al. Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia 2010, 51:1069-1077. [Erratum in: Epilepsia 2010;51:1922].
37. Hanley J.A., Lippman-Hand A. If nothing goes wrong, is everything all right? Interpreting zero numerators. JAMA 1983, 249:1743-1745.
38. Berg A.T., Levy S.R., Testa F.M., D'Souza R. Remission of epilepsy after two drug failures in children: a prospective study. Ann Neurol 2009, 65:510-519.
39. Sillanpää M., Schmidt D. Is incident drug-resistance of childhood-onset epilepsy reversible? A long-term follow-up study. Brain 2012, 135:2256-2262.
40. Schiller Y. Seizure relapse and development of drug resistance following long-term seizure remission. Arch Neurol 2009, 66:1233-1239.
41. Semah F., Picot M.C., Adam C., Broglin D., Arzimanoglou A., Bazin B., et al. Is the underlying cause of epilepsy a major prognostic factor for recurrence?. Neurology 1998, 51:1256-1262.
42. Trinka E., Martin F., Luef G., Unterberger I., Bauer G. Chronic epilepsy with complex partial seizures is not always medically intractable - a long-term observational study. Acta Neurol Scand 2001, 103:219-225.
43. Kwan P., Brodie M.J. Early identification of refractory epilepsy. N Engl J Med 2000, 342:314-319.
44. Hao X., Goldberg D., Kelly K., Stephen L., Kwan P., Brodie M.J. Uncontrolled epilepsy is not necessarily the same as drug-resistant epilepsy: differences between populations with newly diagnosed epilepsy and chronic epilepsy. Epilepsy Behav 2013, 29:4-6.
45. Chadwick D., Smith D. The misdiagnosis of epilepsy. Br Med J 2002, 324:495-496.
46. Thomas P., Valton L., Genton P. Absence and myoclonic status epilepticus precipitated by antiepileptic drugs in idiopathic generalized epilepsy. Brain 2006, 129:1281-1292.
47. Kanner A.M. Common errors made in the diagnosis and treatment of epilepsy. Semin Neurol 2008, 28:364-378.
48. Larch J., Unterberger I., Bauer G., Reichsoellner J., Kuchukhidze G., Trinka E. Myoclonic status epilepticus in juvenile myoclonic epilepsy. Epileptic Disord 2009, 11:309-314.
49. Leach J.P., Lauder R., Nicolson A., Smith D.F. Epilepsy in the UK: misdiagnosis, mistreatment, and undertreatment? The Wrexham area epilepsy project. Seizure 2005, 14:514-520.
50. Kwan P., Schachter S.C., Brodie M.J. Drug-resistant epilepsy. N Engl J Med 2011, 365:919-926.
51. World Health Organization (WHO) Disease Burden: Regional Estimates for 2000-2011 2014, Available at www.who.int/healthinfo/global_burden_disease/estimates_regional/en/index1.htmlAccessed Jan. 7, 2014.
52. Kerr M.P. The impact of epilepsy on patients' lives. Acta Neurol Scand 2012, 126(Suppl. 194):1-9.
53. Berg A.T., Nickels K., Wirrell E.C., Geerts A.T., Callenbach P.M., Arts W.F., et al. Mortality risks in new-onset childhood epilepsy. Pediatrics 2013, 132:124-131.
54. Ding D., Wang W., Wu J., Yang H., Li S., Dai X., et al. Premature mortality risk in people with convulsive epilepsy: long follow-up of a cohort in rural China. Epilepsia 2013, 54:512-517.
55. Fazel S., Wolf A., Långström N., Newton C.R., Lichtenstein P. Premature mortality in epilepsy and the role of psychiatric comorbidity: a total population study. Lancet 2013, 382:1646-1654.
56. Holst A.G., Winkel B.G., Risgaard B., Nielsen J.B., Rasmussen P.V., Haunsø S., et al. Epilepsy and risk of death and sudden unexpected death in the young: a nationwide study. Epilepsia 2013, 54:1613-1620.
57. Nevalainen O., Raitanen J., Ansakorpi H., Artama M., Isojärvi J., Auvinen A. Long-term mortality risk by cause of death in newly diagnosed patients with epilepsy in Finland: a nationwide register-based study. Eur J Epidemiol 2013, 28:981-990.
58. Novy J., Belluzzo M., Caboclo L.O., Catarino C.B., Yogarajah M., Martinian L., et al. The lifelong course of chronic epilepsy: the Chalfont experience. Brain 2013, 136:3187-3199.
59. Shorvon S.D., Goodridge D.M. Longitudinal cohort studies of the prognosis of epilepsy: contribution of the National General Practice Study of Epilepsy and other studies. Brain 2013, 136:3497-3510.
60. Sillanpää M., Shinnar S. SUDEP and other causes of mortality in childhood-onset epilepsy. Epilepsy Behav 2013, 28:249-255.
61. So E. Summary of Session I: Mortality in Epilepsy. In: Partners Against Mortality in Epilepsy Conference Summary. Epilepsy Curr 2013, 13:6-8.
62. Hesdorffer D.C. Risk factors for mortality in epilepsy: which ones are correctible?. In: Partners Against Mortality in Epilepsy Conference Summary. Epilepsy Curr 2013, 13:6.
63. Berg A.T. Mortality in childhood onset epilepsy. In: Partners Against Mortality in Epilepsy Conference Summary. Epilepsy Curr 2013, 13:6-7.
64. Sillanpää M., Shinnar S. Long-term mortality in childhood-onset epilepsy. N Engl J Med 2010, 363:2522-2529.
65. Neligan A., Bell G.S., Johnson A.L., Goodridge D.M., Shorvon S.D., Sander J.W. The long-term risk of premature mortality in people with epilepsy. Brain 2011, 134:388-395.
66. Mintzer S. Antiepileptic drugs and cardiovascular disease. In: Partners Against Mortality in Epilepsy Conference Summary. Epilepsy Curr 2013, 13:7-8.
67. Nilsson L., Tomson T., Farahmand B.Y., Diwan V., Persson P.G. Cause-specific mortality in epilepsy: a cohort study of more than 9,000 patients once hospitalized for epilepsy. Epilepsia 1997, 38:1062-1068.
68. Bell G.S., Gaitatzis A., Bell C.L., Johnson A.L., Sander J.W. Suicide in people with epilepsy: how great is the risk?. Epilepsia 2009, 50:1933-1942.
69. Kanner A.M. Suicide in epilepsy: identifying risks and steps to prevention. In: Partners Against Mortality in Epilepsy Conference Summary. Epilepsy Curr 2013, 13:6-7.
70. Shackleton D.P., Westendorp R.G., Trenité D.G., Vandenbroucke J.P. Mortality in patients with epilepsy: 40 years of follow up in a Dutch cohort study. J Neurol Neurosurg Psychiatry 1999, 66:636-640.
71. Bell G.S., Gaitatzis A., Bell C.L., Johnson A.L., Sander J.W. Drowning in people with epilepsy: how great is the risk?. Neurology 2008, 71:578-582.
72. Nashef L., So E.L., Ryvlin P., Tomson T. Unifying the definitions of sudden unexpected death in epilepsy. Epilepsia 2012, 53:227-233.
73. Thurman D.J. The epidemiology of SUDEP: a public health perspective. In: Partners Against Mortality in Epilepsy Conference Summary. Epilepsy Curr 2013, 13:9.
74. Devinsky O. Sudden, unexpected death in epilepsy. N Engl J Med 2011, 365:1801-1811.
75. Hirsch L.J., Donner E.J., So E.L., Jacobs M., Nashef L., Noebels J.L., et al. Abbreviated report of the NIH/NINDS workshop on sudden unexpected death in epilepsy. Neurology 2011, 76:1932-1938.
76. Shorvon S., Tomson T. Sudden unexpected death in epilepsy. Lancet 2011, 378:2028-2038.
77. Lamberts R.J., Thijs R.D., Laffan A., Langan Y., Sander J.W. Sudden unexpected death in epilepsy: people with nocturnal seizures may be at highest risk. Epilepsia 2012, 53:253-257.
78. Langan Y., Nashef L., Sander J.W. Case-control study of SUDEP. Neurology 2005, 64:1131-1133.
79. Walczak T.S., Leppik I.E., D'Amelio M., Rarick J., So E., Ahman P., et al. Incidence and risk factors in sudden unexpected death in epilepsy: a prospective cohort study. Neurology 2001, 56:519-525.
80. Hesdorffer D.C., Tomson T. Sudden unexpected death in epilepsy. Potential role of antiepileptic drugs. CNS Drugs 2013, 27:113-119.
81. Hesdorffer D.C., Tomson T., Benn E., Sander J.W., Nilsson L., Langan Y., et al. ILAE Commission on Epidemiology (Subcommission on Mortality). Do antiepileptic drugs or generalized tonic-clonic seizure frequency increase SUDEP risk? A combined analysis. Epilepsia 2012, 53:249-252.
82. Ryvlin P., Cucherat M., Rheims S. Risk of sudden unexpected death in epilepsy in patients given adjunctive antiepileptic treatment for refractory seizures: a meta-analysis of placebo-controlled randomised trials. Lancet Neurol 2011, 10:961-968.
83. Faught E., Duh M.S., Weiner J.R., Guérin A., Cunnington M.C. Nonadherence to antiepileptic drugs and increased mortality: findings from the RANSOM Study. Neurology 2008, 71:1572-1578.
84. Bateman L.M., Li C.S., Seyal M. Ictal hypoxemia in localization-related epilepsy: analysis of incidence, severity and risk factors. Brain 2008, 131:3239-3245.
85. Richerson G.B. Serotonin: The Anti-SuddenDeathAmine?. Epilepsy Curr 2013, 13:241-244.
86. Richerson G.B., Buchanan G.F. The serotonin axis: Shared mechanisms in seizures, depression, and SUDEP. Epilepsia 2011, 52(Suppl. 1):28-38.
87. Faingold C.L., Randall M. Effects of age, sex, and sertraline administration on seizure-induced respiratory arrest in the DBA/1 mouse model of sudden unexpected death in epilepsy (SUDEP). Epilepsy Behav 2013, 28:78-82.
88. Tupal S., Faingold C.L. Evidence supporting a role of serotonin in modulation of sudden death induced by seizures in DBA/2 mice. Epilepsia 2006, 47:21-26.
89. Lhatoo S.D., Faulkner H.J., Dembny K., Trippick K., Johnson C., Bird J.M. An electroclinical case-control study of sudden unexpected death in epilepsy. Ann Neurol 2010, 68:787-796.
90. Surges R., Strzelczyk A., Scott C.A., Walker M.C., Sander J.W. Postictal generalized electroencephalographic suppression is associated with generalized seizures. Epilepsy Behav 2011, 21:271-274.
91. Glasscock E. Genomic biomarkers of SUDEP in brain and heart. Epilepsy Behav 2013, [Oct 16. pii: S1525-5050(13)00485-X, E-pub ahead of print]. 10.1016/j.yebeh.2013.09.019.
92. Sowers L.P., Massey C.A., Gehlbach B.K., Granner M.A., Richerson G.B. Sudden unexpected death in epilepsy: fatal post-ictal respiratory and arousal mechanisms. Respir Physiol Neurobiol 2013, 189:315-323.
93. Ryvlin P., Nashef L., Tomson T. Prevention of sudden unexpected death in epilepsy: a realistic goal?. Epilepsia 2013, 54(Suppl. 2):23-28.
94. Surges R., Sander J.W. Sudden unexpected death in epilepsy: mechanisms, prevalence, and prevention. Curr Opin Neurol 2012, 25:201-207.
95. Terra V.C., Cysneiros R., Cavalheiro E.A., Scorza F.A. Sudden unexpected death in epilepsy: from the lab to the clinic setting. Epilepsy Behav 2013, 26:415-420.
96. Tolstykh G.P., Cavazos J.E. Potential mechanisms of sudden unexpected death in epilepsy. Epilepsy Behav 2013, 26:410-414.
97. Ryvlin P., Nashef L., Lhatoo S.D., Bateman L.M., Bird J., Bleasel A., et al. Incidence and mechanisms of cardiorespiratory arrests in epilepsy monitoring units (MORTEMUS): a retrospective study. Lancet Neurol 2013, 12:966-977.
98. Bell G.S., Sinha S., Tisi J.D., Stephani C., Scott C.A., Harkness W.F., et al. Premature mortality in refractory partial epilepsy: Does surgical treatment make a difference?. J Neurol Neurosurg Psychiatry 2010, 81:716-718.
99. Perry M.S., Duchowny M. Surgical versus medical treatment for refractory epilepsy: Outcomes beyond seizure control. Epilepsia 2013, 54:2060-2070.
100. Sperling M.R., Feldman H., Kinman J., Liporace J.D., O'Connor M.J. Seizure control and mortality in epilepsy. Ann Neurol 1999, 46:45-50.
101. Salanova V., Markand O., Worth R. Temporal lobe epilepsy: analysis of failures and the role of reoperation. Acta Neurol Scand 2005, 111:126-133.
102. Jehi L. Sudden death in epilepsy, surgery, and seizure outcomes: the interface between heart and brain. Cleve Clin J Med 2010, 77(Suppl. 3):S51-S55.
103. Nashef L., Fish D.R., Garner S., Sander J.W., Shorvon S.D. Sudden death in epilepsy: a study of incidence in a young cohort with epilepsy and learning difficulty. Epilepsia 1995, 36:1187-1194.
104. Beniczky S., Polster T., Kjaer T.W., Hjalgrim H. Detection of generalized tonic-clonic seizures by a wireless wrist accelerometer: a prospective, multicenter study. Epilepsia 2013, 54:e58-e61.
105. Poppel K.V., Fulton S.P., McGregor A., Ellis M., Patters A., Wheless J. Prospective study of the Emfit Movement Monitor. J Child Neurol 2013, 28:1434-1436.
106. Berg A.T., Berkovic S.F., Brodie M.J., Buchhalter J., Cross J.H., van Emde Boas W., et al. Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005-2009. Epilepsia 2010, 51:676-685.
107. Annegers J.F., Hauser W.A., Elveback L.R. Remission of seizures and relapse in patients with epilepsy. Epilepsia 1979, 20:729-737.
108. Berg A.T., Shinnar S. Do seizures beget seizures? An assessment of the clinical evidence in humans. J Clin Neurophysiol 1997, 14:102-110.
109. Coan A.C., Cendes F. Epilepsy as progressive disorders: what is the evidence that can guide our clinical decisions and how can neuroimaging help?. Epilepsy Behav 2013, 26:313-321.
110. Holtkamp M., Schuchmann S., Gottschalk S., Meierkord H. Recurrent seizures do not cause hippocampal damage. J Neurol 2004, 251:458-463.
111. Sutula T.P. Mechanisms of epilepsy progression: current theories and perspectives from neuroplasticity in adulthood and development. Epilepsy Res 2004, 60:161-171.
112. Helmstaedter C., Elger C.E. Chronic temporal lobe epilepsy: a neurodevelopmental or progressively dementing disease?. Brain 2009, 132:2822-2830.
113. Hermann B.P., Seidenberg M., Bell B. The neurodevelopmental impact of childhood onset temporal lobe epilepsy on brain structure and function and the risk of progressive cognitive effects. Prog Brain Res 2002, 135:429-438.
114. Janz D. Epilepsy with impulsive petit mal (juvenile myoclonic epilepsy). Acta Neurol Scand 1985, 52:449-459.
115. Camfield C.S., Camfield P.R. Juvenile myoclonic epilepsy 25 years after seizure onset: a population-based study. Neurology 2009, 73:1041-1045.
116. Moschetta S., Valente K.D. Impulsivity and seizure frequency, but not cognitive deficits, impact social adjustment in patients with juvenile myoclonic epilepsy. Epilepsia 2013, 54:866-870.
117. Bernhardt B.C., Rozen D.A., Worsley K.J., Evans A.C., Bernasconi N., Bernasconi A. Thalamo-cortical network pathology in idiopathic generalized epilepsy: insights from MRI-based morphometric correlation analysis. Neuroimage 2009, 46:373-381.
118. Briellmann R.S., Berkovic S.F., Jackson G.D. Men may be more vulnerable to seizure-associated brain damage. Neurology 2000, 55:1479-1485.
119. Briellmann R.S., Newton M.R., Wellard R.M., Jackson G.D. Hippocampal sclerosis following brief generalized seizures in adulthood. Neurology 2001, 57:315-317.
120. Kälviäinen R., Salmenperä T., Partanen K., Vainio P., Riekkinen P., Pitkänen A. Recurrent seizures may cause hippocampal damage in temporal lobe epilepsy. Neurology 1998, 50:1377-1382.
121. Liu R.S., Lemieux L., Bell G.S., Sisodiya S.M., Bartlett P.A., Shorvon S.D., et al. The structural consequences of newly diagnosed seizures. Ann Neurol 2002, 52:573-580.
122. Tasch E., Cendes F., Li L.M., Dubeau F., Andermann F., Arnold D.L. Neuroimaging evidence of progressive neuronal loss and dysfunction in temporal lobe epilepsy. Ann Neurol 1999, 45:568-576.
123. Shinnar S., Bello J.A., Chan S., Hesdorffer D.C., Lewis D.V., Macfall J., et al. FEBSTAT Study Team MRI abnormalities following febrile status epilepticus in children: the FEBSTAT study. Neurology 2012, 79:871-877.
124. Yasuda C.L., Morita M.E., Alessio A., Pereira A.R., Balthazar M.L., Saúde A.V., et al. Relationship between environmental factors and gray matter atrophy in refractory MTLE. Neurology 2010, 74:1062-1068.
125. Conz L., Morita M.E., Coan A.C., Kobayashi E., Yasuda C.L., Pereira A.R., et al. Longitudinal MRI volumetric evaluation in patients with familial mesial temporal lobe epilepsy. Front Neurol 2011, 2:5.
126. Labate A., Cerasa A., Aguglia U., Mumoli L., Quattrone A., Gambardella A. Neocortical thinning in "benign" mesial temporal lobe epilepsy. Epilepsia 2011, 52:712-717.
127. Campos B.A., Yasuda C.L., Castellano G., Bilevicius E., Li L.M., Cendes F. Proton MRS may predict AED response in patients with TLE. Epilepsia 2010, 51:783-788.
128. Garcia P.A., Laxer K.D., van der Grond J., Hugg J.W., Matson G.B., Weiner M.W. Correlation of seizure frequency with N-acetyl-aspartate levels determined by 1H magnetic resonance spectroscopic imaging. Magn Res Imaging 1997, 15:475-478.
129. Gross D.W., Concha L., Beaulieu C. Extratemporal white matter abnormalities in mesial temporal lobe epilepsy demonstrated with diffusion tensor imaging. Epilepsia 2006, 47:1360-1363.
130. Mueller S.G., Laxer K.D., Barakos J., Cheong I., Garcia P., Weiner M.W. Widespread neocortical abnormalities in temporal lobe epilepsy with and without mesial sclerosis. Neuroimage 2009, 46:353-359.
131. Mueller S.G., Ebel A., Barakos J., Scanlon C., Cheong I., Finlay D., et al. Widespread extrahippocampal NAA/(Cr+Cho) abnormalities in TLE with and without mesial temporal sclerosis. J Neurol 2011, 258:603-612.
132. Scanlon C., Mueller S.G., Cheong I., Hartig M., Weiner M.W., Laxer K.D. Grey and white matter abnormalities in temporal lobe epilepsy with and without mesial temporal sclerosis. J Neurol 2013, 260:2320-2329.
133. Bonilha L., Rorden C., Appenzeller S., Coan A.C., Cendes F., Li L.M. Gray matter atrophy associated with duration of temporal lobe epilepsy. Neuroimage 2006, 32:1070-1079.
134. Bernhardt B.C., Worsley K.J., Kim H., Evans A.C., Bernasconi A., Bernasconi N. Longitudinal and cross-sectional analysis of atrophy in pharmacoresistant temporal lobe epilepsy. Neurology 2009, 72:1747-1754.
135. Briellmann R.S., Berkovic S.F., Syngeniotis A., King M.A., Jackson G.D. Seizure-associated hippocampal volume loss: a longitudinal magnetic resonance study of temporal lobe epilepsy. Ann Neurol 2002, 51:641-644.
136. Cendes F. Progressive hippocampal and extrahippocampal atrophy in drug resistant epilepsy. Curr Opin Neurol 2005, 18:173-177.
137. Coan A.C., Appenzeller S., Bonilha L., Li L.M., Cendes F. Seizure frequency and lateralization affect progression of atrophy in temporal lobe epilepsy. Neurology 2009, 73:834-842.
138. Fuerst D., Shah J., Shah A., Watson C. Hippocampal sclerosis is a progressive disorder: a longitudinal volumetric MRI study. Ann Neurol 2003, 53:413-416.
139. Cendes F., Andermann F., Dubeau F., Matthews P.M., Arnold D.L. Normalization of neuronal metabolic dysfunction after surgery for temporal lobe epilepsy Evidence from proton MR spectroscopic imaging. Neurology 1997, 49:1525-1533.
140. Hugg J.W., Kuzniecky R.I., Gilliam F.G., Morawetz R.B., Fraught R.E., Hetherington H.P. Normalization of contralateral metabolic function following temporal lobectomy demonstrated by 1H magnetic resonance spectroscopic imaging. Ann Neurol 1996, 40:236-239.
141. Yasuda C.L., Valise C., Saúde A.V., Pereira A.R., Pereira F.R., Ferreira Costa A.L., et al. Dynamic changes in white and gray matter volume are associated with outcome of surgical treatment in temporal lobe epilepsy. Neuroimage 2010, 49:71-79.
142. Gloor P. The temporal lobe and limbic system 1999, Oxford University Press, New York.
143. Brandt C., Ebert U., Loscher W. Epilepsy induced by extended amygdala-kindling in rats: lack of clear association between development of spontaneous seizures and neuronal damage. Epilepsy Res 2004, 62:135-156.
144. Bartolomei F., Chauvel P., Wendling F. Epileptogenicity of brain structures in human temporal lobe epilepsy: a quantified study from intracerebral EEG. Brain 2008, 131:1818-1830.
145. Fahoum F., Lopes R., Pittau F., Dubeau F., Gotman J. Widespread epileptic networks in focal epilepsies-EEG-fMRI study. Epilepsia 2012, 53:1618-1627.
146. Helmstaedter C., Kurthen M., Lux S., Reuber M., Elger C.E. Chronic epilepsy and cognition: a longitudinal study in temporal lobe epilepsy. Ann Neurol 2003, 54:425-432.
147. Hermann B.P., Seidenberg M., Dow C., Jones J., Rutecki P., Bhattacharya A., et al. Cognitive prognosis in chronic temporal lobe epilepsy. Ann Neurol 2006, 60:80-87.
148. MacDonald B.K., Johnson A.L., Goodridge D.M., Cockerell O.C., Sander J.W., Shorvon S.D. Factors predicting prognosis of epilepsy after presentation with seizures. Ann Neurol 2000, 48:833-841.
149. Morrell F. Varieties of human secondary epileptogenesis. J Clin Neurophysiol 1989, 6:227-275.
150. Gowers W.R. Epilepsy and other chronic convulsive disorders: their causes, symptoms and treatment 1881, J&A Churchill, London.
151. Cendes F., Andermann F., Gloor P., Lopes-Cendes I., Andermann E., Melanson D., et al. Atrophy of mesial structures in patients with temporal lobe epilepsy: cause or consequence of repeated seizures?. Ann Neurol 1993, 34:795-801.
152. Malmgren K., Thom M. Hippocampal sclerosis-origins and imaging. Epilepsia 2012, 53(Suppl. 4):19-33.
153. Mathern G.W., Adelson P.D., Cahan L.D., Leite J.P. Hippocampal neuron damage in human epilepsy: Meyer's hypothesis revisited. Prog Brain Res 2002, 135:237-251.
154. Thom M., Zhou J., Martinian L., Sisodiya S. Quantitative post-mortem study of the hippocampus in chronic epilepsy: seizures do not inevitably cause neuronal loss. Brain 2005, 128:1344-1357.
155. VanLandingham K.E., Heinz E.R., Cavazos J.E., Lewis D.V. Magnetic resonance imaging evidence of hippocampal injury after prolonged focal febrile convulsions. Ann Neurol 1998, 43:413-426.
156. Nairismägi J., Gröhn O.H., Kettunen M.I., Nissinen J., Kauppinen R.A., Pitkänen A. Progression of brain damage after status epilepticus and its association with epileptogenesis: a quantitative MRI study in a rat model of temporal lobe epilepsy. Epilepsia 2004, 45:1024-1034.
157. Pohlmann-Eden B., Gass A., Peters C.N., Wennberg R., Blumcke I. Evolution of MRI changes and development of bilateral hippocampal sclerosis during long lasting generalized status epilepticus. J Neurol Neurosurg Psychiatry 2004, 75:898-900.
158. Scott R.C., Gadian D.G., King M.D., Chong W.K., Cox T.C., Neville B.G., et al. Magnetic resonance imaging findings within 5 days of status epilepticus in childhood. Brain 2002, 125:1951-1959.
159. Scott R.C., King M.D., Gadian D.G., Neville B.G., Connelly A. Hippocampal abnormalities after prolonged febrile convulsion: a longitudinal MRI study. Brain 2003, 126:2551-2557.
160. Kobayashi E., Lopes-Cendes I., Guerreiro C.A., Sousa S.C., Guerreiro M.M., Cendes F. Seizure outcome and hippocampal atrophy in familial mesial temporal lobe epilepsy. Neurology 2001, 56:166-172.
161. Kobayashi E., Li L.M., Lopes-Cendes I., Cendes F. Magnetic resonance imaging evidence of hippocampal sclerosis in asymptomatic, first-degree relatives of patients with familial mesial temporal lobe epilepsy. Arch Neurol 2002, 59:1891-1894.
162. Morita M.E., Yasuda C.L., Betting L.E., Pacagnella D., Conz L., Barbosa P.H., et al. MRI and EEG as long-term seizure outcome predictors in familial mesial temporal lobe epilepsy. Neurology 2012, 79:2349-2354.
163. Meyer A., Falconer M.A. Pathological findings in temporal lobe epilepsy. J Neurol Neurosurg Psychiat 1954, 17:276-285.
164. Falconer M.A., Taylor D.C. Surgical treatment of drug-resistant epilepsy due to mesial temporal sclerosis Etiology and significance. Arch Neurol 1968, 19:353-361.
165. Meencke H.J. Clinical neuropathology of the epilepsies in the 100 years of the ILAE (1909-2009). Epilepsia 2009, 50(Suppl. 3):8-16.
166. O'Brien T.J., So E.L., Meyer F.B., Parisi J.E., Jack C.R. Progressive hippocampal atrophy in chronic intractable temporal lobe epilepsy. Ann Neurol 1999, 45:526-529.
167. Bilevicius E., Yasuda C.L., Silva M.S., Guerreiro C.A., Lopes-Cendes I., Cendes F. ntiepileptic drug response in temporal lobe epilepsy: a clinical and MRI morphometry study. Neurology 2010, 75:1695-1701.
168. Pulsipher D.T., Seidenberg M., Morton J.J., Geary E., Parrish J., Hermann B. MRI volume loss of subcortical structures in unilateral temporal lobe epilepsy. Epilepsy Behav 2007, 11:442-449.
169. Liu R.S., Lemieux L., Bell G.S., Hammers A., Sisodiya S.M., Bartlett P.A., et al. Progressive neocortex damage in epilepsy. Ann Neurol 2003, 53:312-324.
170. Van Paesschen W., Duncan J.S., Stevens J.M., Connelly A. Longitudinal quantitative hippocampal magnetic resonance imaging study of adults with newly diagnosed partial seizures: one-year follow-up results. Epilepsia 1998, 39:633-639.
171. Bernasconi N., Natsume J., Bernasconi A. Progression in temporal lobe epilepsy: differential atrophy in mesial temporal structures. Neurology 2005, 65:223-228.
172. Seidenberg M., Hermann B., Pulsipher D., Morton J., Parrish J., Geary E., et al. Thalamic atrophy and cognition in unilateral temporal lobe epilepsy. J Int Neuropsychol Soc 2008, 14:384-393.
173. Tosun D., Dabbs K., Caplan R., Siddarth P., Toga A., Seidenberg M., et al. Deformation-based morphometry of prospective neurodevelopmental changes in new onset paediatric epilepsy. Brain 2011, 134:1003-1014.
174. Feksi A.T., Kaamugisha J., Sander J.W., Gatiti S., Shorvon S.D. Comprehensive primary health care antiepileptic drug treatment programme in rural and semi-urban Kenya. ICBERG (International Community-based Epilepsy Research Group). Lancet 1991, 337:406-409.
175. Placencia M., Sander J.W., Shorvon S.D., Roman M., Alarcon F., Bimos C., et al. Antiepileptic drug treatment in a community health care setting in northern Ecuador: a prospective 12-month assessment. Epilepsy Res 1993, 14:237-244.
176. Reynolds E.H. Early treatment and prognosis of epilepsy. Epilepsia 1987, 28:97-106.
177. Goddard G.V. Development of epileptic seizures through brain stimulation at low intensity. Nature 1967, 214:1020-1021.
178. Sato M., Nakashima T. Kindling: secondary epileptogenesis, sleep and catecholamines. Can J Neurol Sci 1975, 2:439-446.
179. Morrell F. Secondary epileptogenesis in man. Arch Neurol 1985, 42:318-335.
180. So N., Gloor P., Quesney L.F., Jones-Gotman M., Jones-Gotman M., Olivier A., et al. Depth electrode investigations in patients with bitemporal epileptiform abnormalities. Ann Neurol 1989, 25:423-431.
181. Patrick S., Berg A., Spencer S.S. EEG and seizure outcome after epilepsy surgery. Epilepsia 1995, 36:236-240.
182. Begley C.E., Famulari M., Annegers J.F., Lairson D.R., Reynolds T.F., Coan S., et al. The cost of epilepsy in the United States: an estimate from population-based clinical and survey data. Epilepsia 2000, 41:342-351.
183. Hermann B.P., Seidenberg M., Bell B., Woodard A., Rutecki P., Sheth R. Comorbid psychiatric symptoms in temporal lobe epilepsy: association with chronicity of epilepsy and impact on quality of life. Epilepsy Behav 2000, 1:184-190.
184. Hermann B.P., Seidenberg M., Bell B. Psychiatric comorbidity in chronic epilepsy: identification, consequences, and treatment of major depression. Epilepsia 2000, 41(Suppl. 2):S31-S41.
185. Hermann B.P., Whitman S. Neurobiological, psychosocial, and pharmacological factors underlying interictal psychopathology in epilepsy. Adv Neurol 1991, 55:439-452.
186. Berg A.T., Langfitt J.T., Testa F.M., Levy S.R., DiMario F., Westerveld M., et al. Global cognitive function in children with epilepsy: a community-based study. Epilepsia 2008, 49:608-614.
187. Berg A.T., Vickrey B.G., Testa F.M., Levy S.R., Shinnar S., DiMario F. Behavior and social competency in idiopathic and cryptogenic childhood epilepsy. Dev Med Child Neurol 2007, 49:487-492.
188. Berg A.T., Smith S.N., Frobish D., Levy S.R., Testa F.M., Beckerman B., et al. Special education needs of children with newly diagnosed epilepsy. Dev Med Child Neurol 2005, 47:749-753.
189. Vickrey B.G., Berg A.T., Sperling M.R., Shinnar S., Langfitt J.T., Bazil C.W., et al. Relationships between seizure severity and health-related quality of life in refractory localization-related epilepsy. Epilepsia 2000, 41:760-764.
190. Camfield P.R., Gates R., Ronen G., Camfield C., Ferguson A., MacDonald G.W. Comparison of cognitive ability, personality profile, and school success in epileptic children with pure right versus left temporal lobe EEG foci. Ann Neurol 1984, 15:122-126.
191. Camfield C.S., Camfield P.R. Long-term social outcomes for children with epilepsy. Epilepsia 2007, 48(Suppl. 9):3-5.
192. Geerts A., Brouwer O., van Donselaar C., Stroink H., Peters B., Peeters E., et al. Health perception and socioeconomic status following childhood-onset epilepsy: the Dutch study of epilepsy in childhood. Epilepsia 2011, 52:2192-2202.
193. Devinsky O., Barr W.B., Vickrey B.G., Berg A.T., Bazil C.W., Pacia S.V., et al. Changes in depression and anxiety after resective surgery for epilepsy. Neurology 2005, 65:1744-1749.
194. Spencer S.S., Berg A.T., Vickrey B.G., Sperling M.R., Bazil C.W., Haut S., et al. Health-Related Quality of Life over Time Since Resective Epilepsy Surgery. Ann Neurol 2007, 62:327-334.
195. Hesdorffer D.C., Hauser W.A., Annegers J.F., Cascino G. Major depression is a risk factor for seizures in older adults. Ann Neurol 2000, 47:246-249.
196. Hesdorffer D.C., Ludvigsson P., Olafsson E., Gudmundsson G., Kjartansson O., Hauser W.A. ADHD as a risk factor for incident unprovoked seizures and epilepsy in children. Arch Gen Psychiatry 2004, 61:731-736.
197. Hesdorffer D.C., Hauser W.A., Olafsson E., Ludvigsson P., Kjartansson O. Depression and suicide attempt as risk factors for incident unprovoked seizures. Ann Neurol 2006, 59:35-41.
198. Joëls M. Stress, the hippocampus, and epilepsy. Epilepsia 2009, 50:586-597.
199. Austin J.K., Harezlak J., Dunn D.W., Huster G.A., Rose D.F., Ambrosius W.T. Behavior problems in children before first recognized seizures. Pediatrics 2001, 107:115-122.
200. Oostrum K.J., Smeets-Schouten A., Kruitwagen C.L., Peters A.C., Jennekens-Schinkel A. Dutch Study Group of Epilepsy in Childhood. Not only a matter of epilepsy: early problems of cognition and behavior in children with "epilepsy only" - a prospective, longitudinal, controlled study starting at diagnosis. Pediatrics 2003, 112:1338-1344.
201. Fastenau P.S., Johnson C.S., Perkins S.M., Byars A.W., de Grauw T.J., Austin J.K., et al. Neuropsychological status at seizure onset in children: risk factors for early cognitive deficits. Neurology 2009, 73:526-534.
202. Hermann B.P., Jones J.E., Sheth R., Koehn M., Becker T., Fine J., et al. Growing up with epilepsy: a two-year investigation of cognitive development in children with new onset epilepsy. Epilepsia 2008, 49:1847-1858.
203. Pulsipher D.T., Hermann B., Seidenberg M., Tuchscherer V.N., Morton J., Sheth R.D., et al. Thalamofrontal circuitry and executive dysfunction in recent-onset juvenile myoclonic epilepsy. Epilepsia 2009, 50:1210-1219.
204. Wandschneider B., Kopp U.A., Kliegel M., Stephani U., Kurlemann G., Janz D., et al. Prospective memory in patients with juvenile myoclonic epilepsy and their healthy siblings. Neurology 2010, 75:2161-2177.
205. Cavalleri G.L., McCormack M., Alhusaini S., Chaila E., Delanty N. Pharmacogenomics and epilepsy: the road ahead. Pharmacogenomics 2011, 12:1429-1447.
206. Perucca P., Gilliam F.G. Adverse effects of antiepileptic drugs. Lancet Neurol 2012, 11:792-802.
207. Perucca E., Tomson T. The pharmacological treatment of epilepsy in adults. Lancet Neurol 2011, 10:446-456.
208. Thomson T., Battino D., Bonizzoni E., Craig J., Lindhout D., Sabers A., et al. EURAP study group. Dose-dependent risk of malformations with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registry. Lancet Neurol 2011, 10:609-617.
209. Brodie M.J., Mintzer S., Pack A.M., Gidal B.E., Vecht C.J., Schmidt D. Enzyme induction with antiepileptic drugs: cause for concern?. Epilepsia 2013, 54:11-27.
210. Chen P., Lin J.J., Lu C.S., Ong C.T., Hsieh P.F., Yang C.C., et al. Taiwan SJS Consortium. Carbamazepine-induced toxic effects and HLA-B*1502 screening in Taiwan. N Engl J Med 2011, 364:1126-1133.
211. McCormack M., Alfirevic A., Bourgeois S., Farrell J.J., Kasperavičiute D., Carrington M., et al. HLA-A*3101 and carbamazepine-induced hypersensitivity reactions in Europeans. N Engl J Med 2011, 364:1134-1143.
212. EpiPGX Consortium (Epilepsy Pharmacogenomics: delivering biomarkers for clinical use) Available at:, [Accessed Jan. 10, 2014]. http://www.epipgx.eu.
213. Bromley R.L., Mawer G.E., Briggs M., Cheyne C., Clayton-Smith J., García-Fiñana M., et al. The prevalence of neurodevelopmental disorders in children prenatally exposed to antiepileptic drugs. J Neurol Neurosurg Psychiatry 2013, 84:637-643.
214. Christensen J., Grønborg T.K., Sørensen M.J., Schendel D., Parner E.T., Pedersen L.H., et al. Prenatal valproate exposure and risk of autism spectrum disorders and childhood autism. JAMA 2013, 309:1696-1703.
215. Kinirons P., Cavalleri G.L., O'Rourke D., Doherty C.P., Reid I., Logan P., et al. Vigabatrin retinopathy in an Irish cohort: lack of correlation with dose. Epilepsia 2006, 47:311-317.
216. Kinirons P., Cavalleri G.L., Singh R., Shahwan A., Acheson J.F., Wood N.W., et al. A pharmacogenetic exploration of vigabatrin-induced visual field constriction. Epilepsy Res 2006, 70:144-152.
217. de Tisi J., Bell G.S., Peacock J.L., McEvoy A.W., Harkness W.F., Sander J.W., et al. The long-term outcome of adult epilepsy surgery, patterns of seizure remission, and relapse: a cohort study. Lancet 2011, 378:1388-1395.
218. Vale F.L., Pollock G., Dionisio J., Benbadis S.R., Tatum W.O. Outcome and complications of chronically implanted subdural electrodes for the treatment of medically resistant epilepsy. Clin Neurol Neurosurg 2013, 115:985-990.
219. Park M.S., Nakagawa E., Schoenberg M.R., Benbadis S.R., Vale F.L. Outcome of corpus callosotomy in adults. Epilepsy Behav 2013, 28:181-184.
220. Beier A.D., Rutka J.T. Hemispherectomy: historical review and recent technical advances. Neurosurg Focus 2013, 34(6):E11. 10.3171/2013.3.
221. Moosa A.N., Gupta A., Jehi L., Marashly A., Cosmo G., Lachhwani D., et al. Longitudinal seizure outcome and prognostic predictors after hemispherectomy in 170 children. Neurology 2013, 80:253-260.
222. Fisher R.S., Handforth A. Reassessment: vagus nerve stimulation for epilepsy: a report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 1999, 53:666-669.
223. Morris G.L., Gloss D., Buchhalter J., Mack K.J., Nickels K., Harden C. Evidence-based guideline update: vagus nerve stimulation for the treatment of epilepsy: report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology 2013, 81:1453-1459.
224. Fisher R., Salanova V., Witt T., Worth R., Henry T., Gross R., et al. Electrical stimulation of the anterior nucleus of thalamus for treatment of refractory epilepsy. Epilepsia 2010, 51:899-908.
225. Morrell M.J., RNS System in Epilepsy Study Group Responsive cortical stimulation for the treatment of medically intractable partial epilepsy. Neurology 2011, 77:1295-1304.
226. Benbadis S., Helmers S., Hirsch L.J., Sirven J., Vale F.L., Wheless J. Yes, neurostimulation has a role in the management of epilepsy. Neurology 2014, [in press].
227. So N.K., Cole A., Tandon N., Slater J.D., Smith M.C. Neurostimulation for the Treatment of Epilepsy: The Skeptical View. Neurology 2014, [in press].
228. Kang H.C., Chung da E., Kim D.W., Kim H.D. Early- and Late-Onset Complications of the Ketogenic Diet for Intractable Epilepsy. Epilepsia 2004, 45:1116-1123.